Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 57

1.

Tissue Imaging by Mass Spectrometry: A Practical Guide for the Medicinal Chemist.

Johnson RW Jr, Talaty N.

ACS Med Chem Lett. 2019 Jan 11;10(2):161-167. doi: 10.1021/acsmedchemlett.8b00480. eCollection 2019 Feb 14.

PMID:
30783497
2.

Quality of Life impact of a Recombinant Zoster Vaccine in adults ≥50 Years of Age.

Curran D, Oostvogels L, Heineman T, Matthews S, McElhaney J, McNeil S, Diez-Domingo J, Lal H, Andrews C, Athan E, Berglund J, Campora L, de Looze F, Korhonen T, Leung E, Levin M, Volpi A, Johnson RW; ZOE-50/70 study group.

J Gerontol A Biol Sci Med Sci. 2018 Jun 27. doi: 10.1093/gerona/gly150. [Epub ahead of print]

PMID:
29955836
3.

Complications of herpes zoster in immunocompetent older adults: Incidence in vaccine and placebo groups in two large phase 3 trials.

Kovac M, Lal H, Cunningham AL, Levin MJ, Johnson RW, Campora L, Volpi A, Heineman TC; ZOE-50/70 Study Group.

Vaccine. 2018 Mar 14;36(12):1537-1541. doi: 10.1016/j.vaccine.2018.02.029. Epub 2018 Feb 17.

4.

Herpes zoster epidemiology, management, and disease and economic burden in Europe: a multidisciplinary perspective.

Johnson RW, Alvarez-Pasquin MJ, Bijl M, Franco E, Gaillat J, Clara JG, Labetoulle M, Michel JP, Naldi L, Sanmarti LS, Weinke T.

Ther Adv Vaccines. 2015 Jul;3(4):109-20. doi: 10.1177/2051013615599151. Review. Erratum in: Ther Adv Vaccines. 2016 Jan;4(1-2):32.

5.
6.

Clinical practice. Postherpetic neuralgia.

Johnson RW, Rice AS.

N Engl J Med. 2014 Oct 16;371(16):1526-33. doi: 10.1056/NEJMcp1403062. Review. No abstract available.

PMID:
25317872
7.

Effects of calibration approaches on the accuracy for LC-MS targeted quantification of therapeutic protein.

Nouri-Nigjeh E, Zhang M, Ji T, Yu H, An B, Duan X, Balthasar J, Johnson RW, Qu J.

Anal Chem. 2014 Apr 1;86(7):3575-84. doi: 10.1021/ac5001477. Epub 2014 Mar 21.

8.

Similar herpes zoster incidence across Europe: results from a systematic literature review.

Pinchinat S, Cebrián-Cuenca AM, Bricout H, Johnson RW.

BMC Infect Dis. 2013 Apr 10;13:170. doi: 10.1186/1471-2334-13-170. Review.

9.

Vaccination against herpes zoster in developed countries: state of the evidence.

Drolet M, Oxman MN, Levin MJ, Schmader KE, Johnson RW, Patrick D, Mansi JA, Brisson M.

Hum Vaccin Immunother. 2013 May;9(5):1177-84. doi: 10.4161/hv.23491. Epub 2013 Jan 16. Review.

10.

Analysis of chloroquine and metabolites directly from whole-body animal tissue sections by liquid extraction surface analysis (LESA) and tandem mass spectrometry.

Parson WB, Koeniger SL, Johnson RW, Erickson J, Tian Y, Stedman C, Schwartz A, Tarcsa E, Cole R, Van Berkel GJ.

J Mass Spectrom. 2012 Nov;47(11):1420-8. doi: 10.1002/jms.3068.

PMID:
23147817
11.

Implementation of proteomic biomarkers: making it work.

Mischak H, Ioannidis JP, Argiles A, Attwood TK, Bongcam-Rudloff E, Broenstrup M, Charonis A, Chrousos GP, Delles C, Dominiczak A, Dylag T, Ehrich J, Egido J, Findeisen P, Jankowski J, Johnson RW, Julien BA, Lankisch T, Leung HY, Maahs D, Magni F, Manns MP, Manolis E, Mayer G, Navis G, Novak J, Ortiz A, Persson F, Peter K, Riese HH, Rossing P, Sattar N, Spasovski G, Thongboonkerd V, Vanholder R, Schanstra JP, Vlahou A.

Eur J Clin Invest. 2012 Sep;42(9):1027-36. doi: 10.1111/j.1365-2362.2012.02674.x. Epub 2012 Apr 21.

12.

Prevention of herpes zoster pain.

Johnson RW, Higa K.

Pain Manag. 2012 Jan;2(1):63-9. doi: 10.2217/pmt.11.81.

PMID:
24654619
13.

Characterization of cis-regulatory elements controlling repo transcription in Drosophila melanogaster.

Johnson RW, Wood JL, Jones BW.

Gene. 2012 Jan 15;492(1):167-76. doi: 10.1016/j.gene.2011.10.032. Epub 2011 Oct 25.

PMID:
22051777
14.

A quantitation method for mass spectrometry imaging.

Koeniger SL, Talaty N, Luo Y, Ready D, Voorbach M, Seifert T, Cepa S, Fagerland JA, Bouska J, Buck W, Johnson RW, Spanton S.

Rapid Commun Mass Spectrom. 2011 Feb 28;25(4):503-10. doi: 10.1002/rcm.4891.

PMID:
21259359
15.

A prospective study of the herpes zoster severity of illness.

Drolet M, Brisson M, Levin MJ, Schmader KE, Oxman MN, Johnson RW, Camden S, Mansi JA.

Clin J Pain. 2010 Oct;26(8):656-66. doi: 10.1097/AJP.0b013e3181eef686.

PMID:
20842005
16.

The impact of herpes zoster and post-herpetic neuralgia on quality-of-life.

Johnson RW, Bouhassira D, Kassianos G, Leplège A, Schmader KE, Weinke T.

BMC Med. 2010 Jun 21;8:37. doi: 10.1186/1741-7015-8-37.

17.

The impact of varicella zoster virus: chronic pain.

Opstelten W, McElhaney J, Weinberger B, Oaklander AL, Johnson RW.

J Clin Virol. 2010 May;48 Suppl 1:S8-13. doi: 10.1016/S1386-6532(10)70003-2. Review.

PMID:
20510265
18.

A GVF Zoster Workshop.

Johnson RW.

J Clin Virol. 2010 May;48 Suppl 1:S1. doi: 10.1016/S1386-6532(10)00188-5. No abstract available.

PMID:
20510261
19.

Herpes zoster and postherpetic neuralgia.

Johnson RW.

Expert Rev Vaccines. 2010 Mar;9(3 Suppl):21-6. doi: 10.1586/erv.10.30. Review.

PMID:
20192714
20.

Coalition of advocates to vaccinate of Western European citizens aged 60 years and older.

Michel JP, Chidiac C, Grubeck-Loebenstein B, Johnson RW, Lambert PH, Maggi S, Moulias R, Nicholson K, Werner H.

Aging Clin Exp Res. 2009 Jun;21(3):254-7.

PMID:
19571651

Supplemental Content

Loading ...
Support Center